Article

COPD Highlights From ATS 2024

Author:
Diego J. Maselli, MD, FCCP
Publish date: June 11, 2024

Highlights in chronic obstructive pulmonary disease (COPD) ATS 2024 include therapeutics tezepelumab, dupilumab, and ensifentrine.